443 related articles for article (PubMed ID: 16626762)
1. Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis.
Fukuda T; Mogami A; Tanaka H; Yoshikawa T; Hisadome M; Komatsu H
Life Sci; 2006 Jul; 79(9):822-7. PubMed ID: 16626762
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
[TBL] [Abstract][Full Text] [Related]
4. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic administration of Y-40138, a multiple cytokine modulator, inhibits concanavalin A-induced hepatitis in mice.
Fukuda T; Mogami A; Hisadome M; Komatsu H
Eur J Pharmacol; 2005 Oct; 523(1-3):137-42. PubMed ID: 16236280
[TBL] [Abstract][Full Text] [Related]
8. Green tea suppresses lipopolysaccharide-induced liver injury in d-galactosamine-sensitized rats.
He P; Noda Y; Sugiyama K
J Nutr; 2001 May; 131(5):1560-7. PubMed ID: 11340116
[TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Wang H; Xu DX; Lv JW; Ning H; Wei W
Toxicology; 2007 Jul; 237(1-3):49-57. PubMed ID: 17602819
[TBL] [Abstract][Full Text] [Related]
10. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
[TBL] [Abstract][Full Text] [Related]
11. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
[TBL] [Abstract][Full Text] [Related]
12. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
14. Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury.
Xiong Q; Hase K; Tezuka Y; Namba T; Kadota S
Life Sci; 1999; 65(4):421-30. PubMed ID: 10421428
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Gong X; Zhang L; Jiang R; Wang CD; Yin XR; Wan JY
J Appl Toxicol; 2014 Mar; 34(3):265-71. PubMed ID: 23620140
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
Li J; Zhang X; Huang H
Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
[TBL] [Abstract][Full Text] [Related]
17. Herbal formula CGX ameliorates LPS/D-galactosamine-induced hepatitis.
Shin JW; Wang JH; Park HJ; Choi MK; Kim HG; Son CG
Food Chem Toxicol; 2011 Jun; 49(6):1329-34. PubMed ID: 21414374
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotection by human epidermal growth factor (hEGF) against experimental hepatitis induced by D-galactosamine (D-galN) or D-GalN/lipopolysaccharide.
Cho JY; Yeon JD; Kim JY; Yoo ES; Yu YH; Park MH
Biol Pharm Bull; 2000 Oct; 23(10):1243-6. PubMed ID: 11041260
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice.
Masaki T; Chiba S; Tatsukawa H; Yasuda T; Noguchi H; Seike M; Yoshimatsu H
Hepatology; 2004 Jul; 40(1):177-84. PubMed ID: 15239101
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury.
Yoshida T; Abe K; Ikeda T; Matsushita T; Wake K; Sato T; Sato T; Inoue H
Eur J Pharmacol; 2007 Dec; 576(1-3):136-42. PubMed ID: 17825282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
